High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia

Oncology Reports

Volumn 33, Issue 4, 2015, Pages 1639-1649

  Organista Nava, Jorge ^a   Gómez Gómez, Yazmín ^b   Illades Aguiar, Berenice ^c   Del Carmen Alarcón Romero, Luz ^c   Saavedra Herrera, Mónica Virginia ^b   Rivera Ramírez, Ana Bertha ^b   Garzón Barrientos, Víctor Hugo ^b   Leyva Vázquez, Marco Antonio ^c  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^b Arturo Beltran Ortega   (Mexico)

^c Guerrero State University   (Mexico)

Author keywords

Acute leukemia; Acute lymphoblastic leukemia; Acute myeloid leukemia; MiR 24; Prognosis in acute leukemia

Indexed keywords

BCR ABL PROTEIN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; HYDROCORTISONE; METHOTREXATE; MICRORNA 24; MITOXANTRONE; TRANSCRIPTION FACTOR RUNX1; ANTINEOPLASTIC AGENT; MICRORNA; MIRN24 MICRORNA, HUMAN; RNA; TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BCR ABL GENE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CASE CONTROL STUDY; CHILD; CHROMOSOME TRANSLOCATION; CONTINUOUS INFUSION; CONTROLLED STUDY; ETV6 RUNX1 GENE; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SURVIVAL TIME; BIOSYNTHESIS; COMPARATIVE STUDY; GENETICS; IMMUNOPHENOTYPING; KAPLAN MEIER METHOD; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE COUNT; MORTALITY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRESCHOOL CHILD; PROGNOSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOPHENOTYPING; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE COUNT; MALE; MICRORNAS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM;

EID: 84924898323     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3787     Document Type: Article

References (33)

1. Dorantes-Acosta E and Pelayo R: Lineage switching in acute leukemias: A consequence of stem cell plasticity? Bone Marrow: 406796, 2012. http://dx.doi.org/10.1155/2012/406796.
2. Daniel-Cravioto A, Gonzalez-Bonilla CR, Mejia-Arangure JM, Perez-Saldivar ML, Fajardo-Gutierrez A, Jimenez-Hernandez E, Hernandez-Serrano M and Bekker-Mendez VC: Genetic rearrangement MLL/AF4 is most frequent in children with acute lymphoblastic leukemias in Mexico City. Leuk Lymphoma 50: 1352-1360, 2009.
3. Pérez-Saldivar ML, Fajardo-Gutiérrez A, Bernáldez-Ríos R, et al: Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology. BMC Cancer 11: 355, 2011.
4. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
5. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006.
6. Calin GA, Ferracin M, Cimmino A, et al: A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801, 2005.
7. G arzon R, Volinia S, Liu CG, et al: MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111: 3183-3189, 2008.
8. Jongen-Lavrencic M, Sun SM, Dijkstra MK, Valk PJ and Löwenberg B: MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 111: 5078-5085, 2008.
9. G eorgantas RW III, Hildreth R, Morisot S, Alder J, Liu CG, Heimfeld S, Calin GA, Croce CM and Civin CI: CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci USA 104: 2750-2755, 2007.
10. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, Rajewsky N, Bender TP and Rajewsky K: miR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159, 2007.
11. Ben-Ami O, Pencovich N, Lotem J, Levanon D and Groner Y: A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis. Proc Natl Acad Sci USA 106: 238-243, 2009.
12. Wang Q, Huang Z, Xue H, Jin C, Ju XL, Han JD and Chen YG: MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood 111: 588-595, 2008.
13. Q in W, Shi Y, Zhao B, Yao C, Jin L, Ma J and Jin Y: miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS One 5: e9429, 2010.
14. Cheng AM, Byrom MW, Shelton J and Ford LP: Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33: 1290-1297, 2005.
15. Lal A, Navarro F, Maher CA, et al: miR-24 inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to 'seedless' 3'UT R microRNA recognition elements. Mol Cell 35: 610-625, 2009.
16. Nguyen T, Rich A and Dahl R: miR-24 promotes the survival of hematopoietic cells. PLoS One 8: e55406, 2013.
17. G ómez-Gómez Y, Organista-Nava J, Saavedra-Herrera MV, Rivera-Ramírez AB, Terán-Porcayo MA, Del Carmen Alarcón-Romero L, Illades-Aguiar B and Leyva-Vázquez MA: Survival and risk of relapse of acute lymphoblastic leukemia in a Mexican population is affected by dihydrofolate reductase gene polymorphisms. Exp Ther Med 3: 665-672, 2012.
18. Seguro-popular: Secretaria de Salud/Seguro Popular A, 2007. Available at: http://seguropopular.col.gob.mx/segpop/. (Accessed May, 2009).
19. Reiter A, Schrappe M, Ludwig WD, et al: Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84: 3122-3133, 1994.
20. Smith M, Arthur D, Camitta B, et al: Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 14: 18-24, 1996.
21. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
22. Shtivelman E, Lifshitz B, Gale RP and Canaani E: Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315: 550-554, 1985.
23. van der Feltz MJ, Shivji MK, Allen PB, Heisterkamp N, Groffen J and Wiedemann LM: Nucleotide sequence of both reciprocal translocation junction regions in a patient with Ph positive acute lymphoblastic leukaemia, with a breakpoint within the first intron of the BCR gene. Nucleic Acids Res 17: 1-10, 1989.
24. Kozu T, Miyoshi H, Shimizu K, Maseki N, Kaneko Y, Asou H, Kamada N and Ohki M: Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood 82: 1270-1276, 1993.
25. Harbott J, Viehmann S, Borkhardt A, Henze G and Lampert F: Incidence of TEL/AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood 90: 4933-4937, 1997.
26. Claxton DF, Liu P, Hsu HB, Marlton P, Hester J, Collins F, Deisseroth AB, Rowley JD and Siciliano MJ: Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood 83: 1750-1756, 1994.
27. D ulucq S, St-Onge G, Gagné V, Ansari M, Sinnett D, Labuda D , Moghrabi A and Krajinovic M: DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL. Blood 111: 3692-3700, 2008.
28. Mi S, Lu J, Sun M, et al: MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc Natl Acad Sci USA 104: 19971-19976, 2007.
29. Daschkey S, Röttgers S, Giri A, Bradtke J, Teigler-Schlegel A, Meister G, Borkhardt A and Landgraf P: MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways. PLoS One 8: e56334, 2013.
30. Z aidi SK, Dowdy CR, van Wijnen AJ, Lian JB, Raza A, Stein JL, Croce CM and Stein GS: Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network. Cancer Res 69: 8249-8255, 2009.
31. O rganista-Nava J, Gómez-Gómez Y, Saavedra-Herrera MV, Rivera-Ramírez AB, Terán-Porcayo MA, Alarcón-Romero LC, Illades-Aguiar B and Leyva-Vázquez MA: Polymorphisms of the ?-glutamyl hydrolase gene and risk of relapse to acute lymphoblastic leukemia in Mexico. Leuk Res 34: 728-732, 2010.
32. Ng SM, Lin HP, Ariffin WA, Zainab AK, Lam SK and Chan LL: Age, sex, haemoglobin level, and white cell count at diagnosis are important prognostic factors in children with acute lymphoblastic leukemia treated with BFM-type protocol. J Trop Pediatr 46: 338-343, 2000.
33. Leyva-Vázquez MA, Organista-Nava J, Gómez-Gómez Y , Contreras-Quiroz A, Flores-Alfaro E and Illades-Aguiar B: Polymorphism G80A in the reduced folate carrier gene and its relationship to survival and risk of relapse in acute lymphoblastic leukemia. J Investig Med 60: 1064-1067, 2012.